Výsledky vyhledávání - "Zoe, Draelos"

A clinical evaluation of a permanent hair dye designed to reduce allergic contact dermatitis and hair damage

Autor: Zoe Draelos

Publikováno v: Journal of Cosmetic Dermatology. 21:3925-3928

Permanent hair dye is the most commonly used anti-aging procedure used by both men and women. However, permanent hair dye can cause irritant contact dermatitis due to ammonia and allergic contact dermatitis due to paraphylenediamine (PPD).This resear

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a52dfd6447bf07c1fc4fa2d58511765
https://doi.org/10.1111/jocd.15212

Zobrazit plný text záznamu

Plný text ve formátu HTML

SUPPLEMENT INDIVIDUAL ARTICLES: Update on Truncal Acne: A Review of Treatments for a Neglected Disease and the Re-Emergence of Tazarotene

Autor: Naiem, Issa, Zoe, Draelos, Emil, Tanghetti, Leon, Kircik

Publikováno v: Journal of drugs in dermatology : JDD. 21(12)

Acne vulgaris of the trunk carries with it a major psychosocial impact and an unmet need for adequate management. Approximately 50% of patients with facial acne also exhibit involvement of the back, chest, and/or upper arms. The trunk poses a therape

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::37ff249db389bec84f3990551c6b48eb
https://pubmed.ncbi.nlm.nih.gov/36468963

Zobrazit plný text záznamu

Efficacy and Safety of Tazarotene 0.045% Lotion in Caucasian Adults With Moderate-to-Severe Acne

Autor: James Del Rosso, Linda Stein Gold, Stephen Tyring, Joshua Zeichner, Valerie Callender, Zoe Draelos, William Werschler, Fran Cook-Bolden, Eric Guenin

Publikováno v: Journal of drugs in dermatology : JDD. 21(10)

While topical retinoids are a mainstay of acne treatment, acne can manifest differently in various skin types. The objective of these post hoc analyses from two pooled phase 3 studies was to examine efficacy and safety of tazarotene 0.045% and qualit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89d935ddb1e964c49d6554d11bf25d09
https://pubmed.ncbi.nlm.nih.gov/36219057

Zobrazit plný text záznamu

Vehicle Formulation Impacts Tolerability and Patient Preference: Comparison of Tretinoin Branded Lotion and Generic Cream

Autor: Zoe Draelos, Emil Tanghetti, Eric Guenin

Publikováno v: Journal of drugs in dermatology : JDD. 21(8)

Topical retinoids like tretinoin are a mainstay of acne treatment but associated cutaneous irritation and drying may lead to poor adherence. As vehicle optimization can improve patient preference and adherence, tretinoin 0.05% lotion (Altrenoreg;) wa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7287d2766e5a82e43edc7b6aed7bca55
https://pubmed.ncbi.nlm.nih.gov/35946981

Zobrazit plný text záznamu

A Randomized, Controlled Trial of Trifarotene Plus Doxycycline for Severe Acne Vulgaris

Autor: James Q, Del Rosso, Sandra Marchese, Johnson, Todd, Schlesinger, Lawrence, Green, Nestor, Sanchez, Edward, Lain, Zoe, Draelos, Jean-Philippe, York, Rajeev, Chavda

Publikováno v: J Clin Aesthet Dermatol

OBJECTIVE: We evaluated the efficacy and safety of trifarotene plus oral doxycycline in acne. METHODS: This was a randomized (2:1 ratio) 12-week, double-blind study of once-daily trifarotene cream 50µg/g plus enteric-coated doxycycline 120mg (T+D) v

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0bff52fa1c2da25fa695e189cb8cfc21
https://pubmed.ncbi.nlm.nih.gov/35942016

Zobrazit plný text záznamu

Efficacy and safety of topical brepocitinib for the treatment of mild-to-moderate atopic dermatitis: a phase IIb, randomized, double-blind, vehicle-controlled, dose-ranging and parallel-group study

Autor: Megan N. Landis, Mark Arya, Stacy Smith, Zoe Draelos, Lisa Usdan, Sanela Tarabar, Vivek Pradhan, Sudeepta Aggarwal, Christopher Banfield, Elena Peeva, Michael S. Vincent, Vanja Sikirica, Jason Xenakis, Jean S. Beebe

Publikováno v: The British journal of dermatologyReferences. 187(6)

Background Atopic dermatitis (AD) is a prevalent inflammatory, pruritic skin disease. The Janus kinase (JAK) pathway is a treatment target. Objectives To assess the efficacy, safety and pharmacokinetics of topical cream brepocitinib, a small-molecule

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cef62276a1c4d898f2ddd859b40f148
https://pubmed.ncbi.nlm.nih.gov/36199210

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání